INTEGRA LIFESCIENCES HOLDINGS CORP Impairment of Long-Lived Assets Held-for-use
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) reported Impairment of Long-Lived Assets Held-for-use of $2.90 million for the 3-month period ending 2024-06-30, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfLongLivedAssetsHeldForUse · last filed 2026-02-26
- INTEGRA LIFESCIENCES HOLDINGS CORP impairment of long-lived assets held-for-use for the quarter ending 2024-06-30 was $2.90M.
| Period end | Impairment of Long-Lived Assets Held-for-use 3 month |
|---|---|
| 2024-06-30 | $2.90M 10-K · filed 2026-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |